Estrogen stimulated migration and invasion of estrogen receptor-negative breast cancer cells involves an ezrin-dependent crosstalk between G protein-coupled receptor 30 and estrogen receptor beta signaling

• Published in: Steroids Vol. 111; pp. 113 - 120
• Main Authors: Zhou, Kewen, Sun, Peng, Zhang, Yaxing, You, Xinchao, Li, Ping, Wang, Tinghuai
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.07.2016
• Subjects: Blotting, Western; Breast Neoplasms - metabolism; Cell invasion; Cell Line, Tumor; Cell migration; Cell Movement - drug effects; Cytoskeletal Proteins - metabolism; ER-negative breast cancer; Estrogen; Estrogen Receptor beta - genetics; Estrogen Receptor beta - metabolism; Estrogens - pharmacology; G protein-coupled receptor 30; Humans; Phosphorylation - drug effects; Receptors, Estrogen - genetics; Receptors, Estrogen - metabolism; Receptors, G-Protein-Coupled - genetics; Receptors, G-Protein-Coupled - metabolism; RNA, Small Interfering - genetics; Signal Transduction - drug effects; TAM; Estrogen; GPR30; MAPK; cAMP; E2; ER; G protein-coupled receptor 30; 4-OHT; Cell invasion; ER-negative breast cancer; Cell migration; ERK
• ISSN: 0039-128X; 1878-5867
• DOI: 10.1016/j.steroids.2016.01.021

Estrogen mediates important cellular activities in estrogen receptor negative (ER-) breast cancer cells via membrane associated G protein-coupled receptor 30 (GPR30). However, the biological role and mechanism of estrogen action on cell motility and invasion in this aggressive kind of tumors remains poorly understood. We showed here that treatment with 17β-estradiol (E2) in ER-negative cancer cells resulted in ezrin-dependent cytoskeleton rearrangement and elicited a stimulatory effect on cell migration and invasion. Mechanistically, E2 induced ezrin activation was mediated by distinct mechanisms in different cell contexts. In SK-BR-3 cells with a high GPR30/ERβ ratio, silencing of GPR30 was able to abolish E2 induced ERK1/2, AKT phosphorylation and ezrin activation, whereas in MDA-MB-231 cells with low GPR30/ERβ ratio, E2 stimulated ezrin activation was mediated by the ERβ/PI3K/AKT signaling pathway. Importantly, we showed that activation of GPR30 signaling significantly prevents ERβ activation induced ezrin phosphorylation, cell migration and invasion, indicating an antagonist effect between GPR30 and ERβ signaling in MDA-MB-231 cells. These findings highlight the important interplay between different estrogen receptors in estrogen induced cell motility and invasiveness in ER-negative breast cancer cells.